For at nedsætte risikoen for leverskade må De ikke anvende Tasmar hvis 1) De har en leversygdom eller 2) blodprøver taget inden behandlingens start viser tegn på leverabnormalitet (prøver for ALAT, alaninaminotransferase, og ASAT, aspartataminotransferase).
To reduce the risk of liver injury you should not use Tasmar if 1) you have liver disease or 2) blood tests done before starting treatment show any liver abnormality (tests of ALT, alanine amino transferase and AST, aspartate amino transferase).